The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection

Antiviral Research

Volumn 145, Issue , 2017, Pages 96-102

  Takano, Tomomi ^a   Endoh, Misaki ^a   Fukatsu, Hiroaki ^a   Sakurada, Haruko ^a   Doki, Tomoyoshi ^a   Hohdatsu, Tsutomu ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Cholesterol; Feline coronavirus; Histone deacetylase inhibitor; NPC1; U18666A

Indexed keywords

1,4 BIS(2 CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE; 3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; ALENDRONIC ACID; AMOROLFINE; CLOMIFENE; FLUINDOSTATIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ITRACONAZOLE; MEVINOLIN; RO 48 8071; SIMVASTATIN; UNCLASSIFIED DRUG; VORINOSTAT; 3-BETA-(2-(DIETHYLAMINO)ETHOXY)ANDROST-5-EN-17-ONE; ANDROSTANE DERIVATIVE; CHOLESTEROL; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; HYPOCHOLESTEROLEMIC AGENT;

ANTIVIRAL ACTIVITY; ARTICLE; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORONAVIRUS INFECTION; CYTOTOXICITY; DOMESTIC CAT; EC50; FELINE CORONAVIRUS; FELINE INFECTIOUS PERITONITIS; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; TYPE 1 FELINE CORONAVIRUS; TYPE 1 FELINE CORONAVIRUS INFECTION; VIRUS REPLICATION; ANIMAL; CAT; DRUG DEVELOPMENT; DRUG EFFECTS; METABOLISM; VIROLOGY;

ANDROSTENES; ANIMALS; ANTICHOLESTEREMIC AGENTS; CATS; CHOLESTEROL; CORONAVIRUS INFECTIONS; CORONAVIRUS, FELINE; DRUG DISCOVERY; FELINE INFECTIOUS PERITONITIS; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; VIRUS REPLICATION;

EID: 85026786726     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2017.07.022     Document Type: Article

References (40)

1. Aizaki, H., Morikawa, K., Fukasawa, M., Hara, H., Inoue, Y., Tani, H., Saito, K., Nishijima, M., Hanada, K., Matuura, Y., Lai, M.M., Miyamura, T., Wakita, T., Suzuki, T., Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J. Virol. 82 (2008), 5715–5724.
2. Carette, J.E., Raaben, M., Wong, A.C., Herbert, A.S., Obernosterer, G., Mulherkar, N., Kuehne, A.I., Kranzusch, P.J., Griffin, A.M., Ruthel, G., Dal Cin, P., Dye, J.M., Whelan, S.P., Chandran, K., Brummelkamp, T.R., Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477 (2011), 340–343.
3. Cenedella, R.J., Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 44 (2009), 477–487.
4. Cenedella, R.J., Jacob, R., Borchman, D., Tang, D., Neely, A.R., Samadi, A., Mason, R.P., Sexton, P., Direct perturbation of lens membrane structure may contribute to cataracts caused by U18666A, an oxidosqualene cyclase inhibitor. J. Lipid Res. 45 (2004), 1232–1241.
5. D'Alessio, A., Al-Lamki, R.S., Bradley, J.R., Pober, J.S., Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am. J. Pathol. 166 (2005), 1273–1282.
6. Dandekar, A.A., Perlman, S., Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 5 (2005), 917–927.
7. Elgner, F., Ren, H., Medvedev, R., Ploen, D., Himmelsbach, K., Boller, K., Hildt, E., The intracellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus. J. Virol. 90 (2016), 11181–11196.
8. Gallagher, T.M., Buchmeier, M.J., Coronavirus spike proteins in viral entry and pathogenesis. Virology 279 (2001), 371–374.
9. de Groot, R.J., Baker, S.C., Baric, R., Enjuanes, L., Gorbalenya, A.E., Holmes, K.V., Perlman, S., Poon, L., Rottier, P.J.M., Talbot, P.J., Woo, P.C.Y., Ziebuhr, J., Family coronaviridae. King, A., Adams, M., Cartens, E., Lefkowitz, E., (eds.) Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses, 2012, Academic Press, San Diego, CA, 806–828.
10. de Haan, C.A.M., Haijema, B.J., Schellen, P., Schreur, P.W., Te Lintelo, E., Vennema, H., Rottier, P.J.M., Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation. J. Virol. 82 (2008), 6078–6083.
11. Van Hamme, E., Dewerchin, H.L., Cornelissen, E., Verhasselt, B., Nauwynck, H.J., Clathrin- and caveolae-independent entry of feline infectious peritonitis virus in monocytes depends on dynamin. J. Gen. Virol. 89 (2008), 2147–2156.
12. Herrewegh, A.A., Smeenk, I., Horzinek, M.C., Rottier, P.J., de Groot, R.J., Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J. Virol. 72 (1998), 4508–4514.
13. Hohdatsu, T., Sasamoto, S., Koyama, H., Antigenic analysis of feline coronaviruses with monoclonal antibodies (MAbs): preparation of MAbs which discriminate between FIPV strain 79-1146 and FECV strain 79-1683. Vet. Microbiol. 28 (1991), 13–24.
14. Hohdatsu, T., Okada, S., Ishizuka, Y., Yamada, H., Koyama, H., The prevalence of types I and II feline coronavirus infections in cats. J. Vet. Med. Sci. 54 (1992), 557–562.
15. Hohdatsu, T., Izumiya, Y., Yokoyama, Y., Kida, K., Koyama, H., Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch. Virol. 143 (1998), 839–850.
16. Honda, A., Matsuzaki, Y., Cholesterol and chronic hepatitis C virus infection. Hepatol. Res. 41 (2011), 697–710.
17. Ko, D.C., Gordon, M.D., Jin, J.Y., Scott, M.P., Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events. Mol. Biol. Cell. 12 (2001), 601–614.
18. Kummrow, M., Meli, M.L., Haessig, M., Goenczi, E., Poland, A., Pedersen, N.C., Hofmann-Lehmann, R., Lutz, H., Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin. Diagn. Lab. Immunol. 12 (2005), 1209–1215.
19. Lu, F., Liang, Q., Abi-Mosleh, L., Das, A., De Brabander, J.K., Goldstein, J.L., Brown, M.S., Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. Elife, 4, 2015 e12177.
20. Mackenzie, J.M., Khromykh, A.A., Parton, R.G., Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2 (2007), 229–239.
21. Motokawa, K., Hohdatsu, T., Aizawa, C., Koyama, H., Hashimoto, H., Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type I. Arch. Virol. 140 (1995), 469–480.
22. Motokawa, K., Hohdatsu, T., Hashimoto, H., Koyama, H., Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol. Immunol. 40 (1996), 425–433.
23. Nomura, R., Kiyota, A., Suzaki, E., Kataoka, K., Ohe, Y., Miyamoto, K., Senda, T., Fujimoto, T., Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J. Virol. 78 (2004), 8701–8708.
24. Pedersen, N.C., An update on feline infectious peritonitis: virology and immunopathogenesis. Vet. J. 201 (2014), 123–132.
25. Pesteanu-Somogyi, L.D., Radzai, C., Pressler, B.M., Prevalence of feline infectious peritonitis in specific cat breeds. J. Feline Med. Surg. 8 (2006), 1–5.
26. Pipalia, N.H., Subramanian, K., Mao, S., Ralph, H., Hutt, D.M., Scott, S.M., Balch, W.E., Maxfield, F.R., Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells. J. Lipid Res. 58 (2017), 695–708.
27. Poh, M.K., Shui, G., Xie, X., Shi, P.Y., Wenk, M.R., Gu, F., U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antivir. Res. 93 (2012), 191–198.
28. Pratelli, A., Colao, V., Role of the lipid rafts in the life cycle of canine coronavirus. J. Gen. Virol. 96 (2015), 331–337.
29. Ren, X., Glende, J., Yin, J., Schwegmann-Wessels, C., Herrler, G., Importance of cholesterol for infection of cells by transmissible gastroenteritis virus. Virus Res. 137 (2008), 220–224.
30. Shoemaker, C.J., Schornberg, K.L., Delos, S.E., Scully, C., Pajouhesh, H., Olinger, G.G., Johansen, L.M., White, J.M., Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PLoS One, 8, 2013, e56265.
31. Simons, K., Ikonen, E., How cells handle cholesterol. Science 290 (2000), 1721–1726.
32. Su, S., Wong, G., Shi, W., Liu, J., Lai, A.C., Zhou, J., Liu, W., Bi, Y., Gao, G.F., Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 24 (2016), 490–502.
33. Takano, T., Satomi, Y., Oyama, Y., Doki, T., Hohdatsu, T., Differential effect of cholesterol on type I and II feline coronavirus infection. Arch. Virol. 161 (2016), 125–133.
34. Terada, Y., Matsui, N., Noguchi, K., Kuwata, R., Shimoda, H., Soma, T., Mochizuki, M., Maeda, K., Emergence of pathogenic coronaviruses in cats by homologous recombination between feline and canine coronaviruses. PLoS One, 9, 2014, e106534.
35. Thorp, E.B., Gallagher, T.M., Requirements for CEACAMs and cholesterol during murine coronavirus cell entry. J. Virol. 78 (2004), 2682–2692.
36. Trinh, M.N., Lu, F., Li, X., Das, A., Liang, Q., De Brabander, J.K., Brown, M.S., Goldstein, J.L., Triazoles inhibit cholesterol export from lysosomes by binding to NPC1. Proc. Natl. Acad. Sci. U. S. A. 114 (2016), 89–94.
37. Wang, Y.T., Chueh, L.L., Wan, C.H., An eight-year epidemiologic study based on baculovirus-expressed type-specific spike proteins for the differentiation of type I and II feline coronavirus infections. BMC Vet. Res., 10, 2014, 186.
38. Wenger, D.A., Sattler, M., Kudoh, T., Snyder, S.P., Kingston, R.S., Niemann-Pick disease: a genetic model in Siamese cats. Science 208 (1980), 1471–1473.
39. de Wit, E., van Doremalen, N., Falzarano, D., Munster, V.J., SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14 (2016), 523–534.
40. Zheng, Y.H., Plemenitas, A., Fielding, C.J., Peterlin, B.M., Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 8460–8465.